Clinical Trial Update: Clinical Study of VG161 in Subjects with Advanced Primary Liver Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical study of VG161 for advanced primary liver cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• VG161

Snippet

Sponsor: CNBG-Virogin Biotech (Shanghai) Ltd. | Conditions: Primary Liver Cancer | Phase 1 | Status: RECRUITING